The possibility to accurately distinguish young individuals with overweight/obesity by assessing insulin sensitivity could provide better and more appropriate therapeutic options, with a different intensity of intervention according to the risk level, and more structured interventions (e.g., multidisciplinary obesity management and/or bariatric surgery) in individuals at higher risk. The gene discussed is INS; the disease is obesity disorder.